ctrl K

Watchlist Price Alert

CNS Pharmaceuticals Inc. (CNSP)

NASDAQ: CNSP · Real-Time Price · USD

1.04

0.03 (2.97%)

At close: Jun 06, 2025, 3:58 PM

1.04

0.01%

After-hours: Jun 06, 2025, 05:46 PM EDT

CNS Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	3.31K	4.13K	11.76K	13.07K	11.1K	1.96K	n/a	n/a
Gross Profit	-3.31K	-4.13K	-11.76K	-13.07K	-11.1K	-1.96K	n/a	n/a
Operating Income	-14.9M	-18.87M	-15.27M	-14.03M	-9.45M	-3.83M	-881.79K	-215.1K
Interest Income	60.26K	27.69K	7.03	9.29	3.26	44.23	n/a	10.22K
Pretax Income	-14.86M	-18.85M	-15.27M	-14.04M	-9.46M	-3.88M	-7.39M	-219.36K
Net Income	-14.86M	-18.85M	-15.27M	-14.5M	-9.46M	-3.88M	-7.39M	-526.47K
Selling & General & Admin	5.61M	4.77M	5.97M	4.68M	4.39M	1.98M	860.52K	182.47K
Research & Development	9.29M	14.1M	9.3M	9.35M	5.06M	1.85M	21.27K	32.64K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-6.46M	n/a
Operating Expenses	14.9M	18.86M	15.27M	14.03M	9.45M	3.83M	881.79K	215.1K
Interest Expense	16.12K	13.8K	7.03K	9.29K	3.26K	44.23K	46.7K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-255.45K
Cost & Expenses	-14.9M	18.87M	15.27M	14.03M	9.45M	3.83M	881.79K	215.1K
Income Tax Expense	n/a	n/a	7.03K	9.29K	3.26K	42.28K	46.7K	-516.25K
Shares Outstanding (Basic)	3.82M	75M	27.23M	17M	11M	10.97M	10.97M	10.97M
Shares Outstanding (Diluted)	3.82M	1.51K	27.23M	17.57M	11.08M	10.97M	10.97M	10.97M
EPS (Basic)	-38.87	-251.35	-560.83	-852.66	-859.81	-353.57	-674.07	-48.01
EPS (Diluted)	-38.87	-250.19	-560.83	-825.04	-853.68	-353.57	-674.07	-48.01
EBITDA	-14.9M	-18.86M	-15.26M	-14.47M	-9.44M	-3.83M	-6.46M	n/a
EBIT	-14.87M	-18.87M	-15.27M	-14.49M	-9.45M	-3.83M	-7.35M	-516.25K
Depreciation & Amortization	3.31K	4.13K	11.76K	13.07K	11.1K	1.96K	881.79K	516.25K